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Background: Guidelines for the treatment of stable angina recommend a resting heart rate of 55-60 bpm.
Methods: Between Nov 2007 and July 2008, a total of 4,047 consecutive outpatients with stable angina (AP) and known coronary artery disease 
(angiography / prior PCI or CABG or MI) were enrolled into the REALITY-Registry to document patients characteristics and chronic medical treatment. 
Heart rate (HR) was measured according to guideline recommendation after a five minutes resting period. We examined patient characteristics for 
quartiles of HR and analysed the determinants for the achievement of recommended HR in clinical practice.
Results: Outpatients with stable angina in Germany were at mean 69 years old and more often male. The patients received aspirin in 83%, 
betablockers in 80%, statins in 83% and ACE-inhibitors in 63%. HR was at mean 66 bpm, still above the recommended targets of 55-60 bpm. Only 
25.3% of patients achieved resting HR <60bpm. The strongest predictor against achieving HR<60 bpm was the presence of atrial fibrillation at 
enrolment. Patients receiving ivabradine were significantly more likely to achieve resting HR<60 bpm (OR 1.66, p<0.01).
Conclusion: In clinical practice in Germany, only one quarter of patients with stable coronary artery disease reached the recommended target 
value for resting HR <60 bpm. Atrial fibrillation was an independent predictor against and chronic therapy with ivabradine an independent predictor 
in favour of achieving resting HR<60 bpm in clinical practice.  
HR <60 bpm
n= 869 (25.3 %)
HR 60-64 bpm
n= 882 (25.6 %)
HR 65-72 bpm
n= 907 (26.4 %)
HR>72 bpm
n= 781 (22.7 %)
Age [years] 69 68 69 69
Female Gender 28.0% 28.1% 31.4% 31.0%
Prior MI 55.5 % 51.2 % 52.1 % 53.5 %
Prior PCI 54.3 % 55.2 % 54.4 % 47.4 %
Prior Bypass 36.1 % 33.0 % 29.8 % 29.3 %
Diabetes mellitus 30.1 % 31.2 % 34.3 % 38.2 %
Multivessel Disease 62.3 % 63.3 % 62.4 % 64.8 %
LV-EF <40% 10.0 % 9.7 % 10.2 % 13.9 %
Betablocker 78.1 % 83.6 % 81.6 % 74.3 %
Ivabradine 10.0 % 5.3 % 6.0 % 7.8 %
Determinants of HR<60/min OR 95% CI
Age [per year] 1.01 0.99-1.02
Female Gender 0.90 0.76-1.01
Prior MI 1.01 0.94-1.29
Prior CABG 1.31 1.09-1.35
Diabetes mellitus 0.86 0.72-1.02
Atrial Fibrillation 0.69 0.51-0.95
Chronic Betablocker therapy 1.00 0.81-1.22
Chronic Ivabradine therapy 1.66 1.23-2.24
